Global Sotalol 麻豆原创 Research Report 2023

Publication ID:

PB501232189

Publication Date:

January 30, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Sotalol is a medication used to treat abnormal heart rhythms. Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties.
Highlights
The global Sotalol market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Sotalol is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Sotalol is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Sotalol include Bayer, GSK, Bristol-Myers Squibb(BMS), Arbor Pharmaceuticals, Cambrex, Arevipharma, Shaanxi Hanjiang Pharmaceutical Group, Samarth Pharma Pvt. Ltd. and Cipla Limited, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sotalol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sotalol.
The Sotalol market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Sotalol market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sotalol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Bayer
GSK
Bristol-Myers Squibb(BMS)
Arbor Pharmaceuticals
Cambrex
Arevipharma
Shaanxi Hanjiang Pharmaceutical Group
Samarth Pharma Pvt. Ltd.
Cipla Limited
Segment by Type
40mg Sotalol
80mg Sotalol
Segment by Application
Sustained Ventricular Tachycardia
Atrial Fibrillation/Flutter
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sotalol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sotalol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Sotalol 麻豆原创 Overview
1.1 Product Overview and Scope of Sotalol
1.2 Sotalol Segment by Type
1.2.1 Global Sotalol 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 40mg Sotalol
1.2.3 80mg Sotalol
1.3 Sotalol Segment by Application
1.3.1 Global Sotalol 麻豆原创 Value by Application: (2023-2029)
1.3.2 Sustained Ventricular Tachycardia
1.3.3 Atrial Fibrillation/Flutter
1.4 Global Sotalol 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Sotalol Revenue 2018-2029
1.4.2 Global Sotalol Sales 2018-2029
1.4.3 Global Sotalol 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sotalol 麻豆原创 Competition by Manufacturers
2.1 Global Sotalol Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Sotalol Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Sotalol Average Price by Manufacturers (2018-2023)
2.4 Global Sotalol Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sotalol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sotalol, Product Type & Application
2.7 Sotalol 麻豆原创 Competitive Situation and Trends
2.7.1 Sotalol 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sotalol Players 麻豆原创 Share by Revenue
2.7.3 Global Sotalol 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sotalol Retrospective 麻豆原创 Scenario by Region
3.1 Global Sotalol 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sotalol Global Sotalol Sales by Region: 2018-2029
3.2.1 Global Sotalol Sales by Region: 2018-2023
3.2.2 Global Sotalol Sales by Region: 2024-2029
3.3 Global Sotalol Global Sotalol Revenue by Region: 2018-2029
3.3.1 Global Sotalol Revenue by Region: 2018-2023
3.3.2 Global Sotalol Revenue by Region: 2024-2029
3.4 North America Sotalol 麻豆原创 Facts & Figures by Country
3.4.1 North America Sotalol 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sotalol Sales by Country (2018-2029)
3.4.3 North America Sotalol Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sotalol 麻豆原创 Facts & Figures by Country
3.5.1 Europe Sotalol 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sotalol Sales by Country (2018-2029)
3.5.3 Europe Sotalol Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sotalol 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Sotalol 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sotalol Sales by Country (2018-2029)
3.6.3 Asia Pacific Sotalol Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sotalol 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Sotalol 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sotalol Sales by Country (2018-2029)
3.7.3 Latin America Sotalol Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sotalol 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Sotalol 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sotalol Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sotalol Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sotalol Sales by Type (2018-2029)
4.1.1 Global Sotalol Sales by Type (2018-2023)
4.1.2 Global Sotalol Sales by Type (2024-2029)
4.1.3 Global Sotalol Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Sotalol Revenue by Type (2018-2029)
4.2.1 Global Sotalol Revenue by Type (2018-2023)
4.2.2 Global Sotalol Revenue by Type (2024-2029)
4.2.3 Global Sotalol Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Sotalol Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sotalol Sales by Application (2018-2029)
5.1.1 Global Sotalol Sales by Application (2018-2023)
5.1.2 Global Sotalol Sales by Application (2024-2029)
5.1.3 Global Sotalol Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Sotalol Revenue by Application (2018-2029)
5.2.1 Global Sotalol Revenue by Application (2018-2023)
5.2.2 Global Sotalol Revenue by Application (2024-2029)
5.2.3 Global Sotalol Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Sotalol Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Sotalol Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer Sotalol Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Sotalol Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Sotalol Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bristol-Myers Squibb(BMS)
6.3.1 Bristol-Myers Squibb(BMS) Corporation Information
6.3.2 Bristol-Myers Squibb(BMS) Description and Business Overview
6.3.3 Bristol-Myers Squibb(BMS) Sotalol Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bristol-Myers Squibb(BMS) Sotalol Product Portfolio
6.3.5 Bristol-Myers Squibb(BMS) Recent Developments/Updates
6.4 Arbor Pharmaceuticals
6.4.1 Arbor Pharmaceuticals Corporation Information
6.4.2 Arbor Pharmaceuticals Description and Business Overview
6.4.3 Arbor Pharmaceuticals Sotalol Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Arbor Pharmaceuticals Sotalol Product Portfolio
6.4.5 Arbor Pharmaceuticals Recent Developments/Updates
6.5 Cambrex
6.5.1 Cambrex Corporation Information
6.5.2 Cambrex Description and Business Overview
6.5.3 Cambrex Sotalol Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cambrex Sotalol Product Portfolio
6.5.5 Cambrex Recent Developments/Updates
6.6 Arevipharma
6.6.1 Arevipharma Corporation Information
6.6.2 Arevipharma Description and Business Overview
6.6.3 Arevipharma Sotalol Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Arevipharma Sotalol Product Portfolio
6.6.5 Arevipharma Recent Developments/Updates
6.7 Shaanxi Hanjiang Pharmaceutical Group
6.6.1 Shaanxi Hanjiang Pharmaceutical Group Corporation Information
6.6.2 Shaanxi Hanjiang Pharmaceutical Group Description and Business Overview
6.6.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Portfolio
6.7.5 Shaanxi Hanjiang Pharmaceutical Group Recent Developments/Updates
6.8 Samarth Pharma Pvt. Ltd.
6.8.1 Samarth Pharma Pvt. Ltd. Corporation Information
6.8.2 Samarth Pharma Pvt. Ltd. Description and Business Overview
6.8.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Samarth Pharma Pvt. Ltd. Sotalol Product Portfolio
6.8.5 Samarth Pharma Pvt. Ltd. Recent Developments/Updates
6.9 Cipla Limited
6.9.1 Cipla Limited Corporation Information
6.9.2 Cipla Limited Description and Business Overview
6.9.3 Cipla Limited Sotalol Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cipla Limited Sotalol Product Portfolio
6.9.5 Cipla Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sotalol Industry Chain Analysis
7.2 Sotalol Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sotalol Production Mode & Process
7.4 Sotalol Sales and 麻豆原创ing
7.4.1 Sotalol Sales Channels
7.4.2 Sotalol Distributors
7.5 Sotalol Customers
8 Sotalol 麻豆原创 Dynamics
8.1 Sotalol Industry Trends
8.2 Sotalol 麻豆原创 Drivers
8.3 Sotalol 麻豆原创 Challenges
8.4 Sotalol 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bayer
GSK
Bristol-Myers Squibb(BMS)
Arbor Pharmaceuticals
Cambrex
Arevipharma
Shaanxi Hanjiang Pharmaceutical Group
Samarth Pharma Pvt. Ltd.
Cipla Limited

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.